Cullen Mitsuo Taniguchi, MD, PhD
Affiliations: | 2000 | Economic and Social History | Linacre College, Oxford University |
| 2008 | Developmental Biology | Harvard Medical School, Boston, MA, United States | |
| 2009-2014 | Radiation Oncology | Stanford University, Palo Alto, CA | |
| 2014- | Radiation Oncology | The University of Texas MD Anderson Cancer Center |
Area:
Radiation Oncology; radiation protection; hypoxia; gastrintestinal cancersWebsite:
https://faculty.mdanderson.org/profiles/cullen_taniguchi.htmlGoogle:
"Cullen Taniguchi"Parents
Sign in to add mentor| C. Ronald Kahn | grad student | 2005 | Harvard Medical School (Neurotree) | |
| ("The dissection of insulin signaling isoforms in vivo: Molecular mechanisms of hepatic insulin action") | ||||
Children
Sign in to add trainee| Ramez Kouzy | post-doc | 2019-2021 | |
| Lauren Colbert | research scientist | The University of Texas MD Anderson Cancer Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Taniguchi CM, Frakes JM, Aguilera TA, et al. (2023) Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. The Lancet. Oncology. 24: 1387-1398 |
| Colbert LE, El Alam MB, Wang R, et al. (2023) Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell |
| Sherry AD, Msaouel P, McCaw ZR, et al. (2023) Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer (Oxford, England : 1990). 194: 113357 |
| Sherry AD, Corrigan KL, Kouzy R, et al. (2023) Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer |
| Florez MA, Jaoude JA, Patel RR, et al. (2023) Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. Jama Network Open. 6: e2313819 |
| Elnaggar JH, Huynh VO, Lin D, et al. (2023) HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development. Frontiers in Immunology. 14: 1051431 |
| Koay EJ, Zaid M, Aliru M, et al. (2022) Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology, Biology, Physics |
| Lin D, Alam MBE, Jaoude JA, et al. (2022) Microbiome Dynamics During Chemoradiotherapy for Anal Cancer. International Journal of Radiation Oncology, Biology, Physics |
| Moningi S, Lei X, Fang P, et al. (2022) Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clinical and Translational Radiation Oncology. 35: 9-16 |
| Okoro CM, Schüler E, Taniguchi CM. (2022) The Therapeutic Potential of FLASH-RT for Pancreatic Cancer. Cancers. 14 |